These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25501959)

  • 41. Centronuclear (myotubular) myopathy.
    Jungbluth H; Wallgren-Pettersson C; Laporte J
    Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy.
    Park YE; Choi YC; Bae JS; Lee CH; Kim HS; Shin JH; Kim DS
    J Clin Neurol; 2014 Jan; 10(1):24-31. PubMed ID: 24465259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy.
    F Almeida C; Bitoun M; Vainzof M
    FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
    González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
    Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy.
    Liu X; Wu H; Gong J; Wang T; Yan C
    Mol Med Rep; 2016 May; 13(5):4273-8. PubMed ID: 27035234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
    James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
    Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy.
    Abath Neto O; Martins Cde A; Carvalho M; Chadi G; Seitz KW; Oliveira AS; Reed UC; Laporte J; Zanoteli E
    Genet Mol Biol; 2015 May; 38(2):147-51. PubMed ID: 26273216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
    Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
    J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
    Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
    Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in dynamin 2 cause dominant centronuclear myopathy.
    Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
    Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease.
    Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and histologic findings in autosomal centronuclear myopathy.
    Jeannet PY; Bassez G; Eymard B; Laforêt P; Urtizberea JA; Rouche A; Guicheney P; Fardeau M; Romero NB
    Neurology; 2004 May; 62(9):1484-90. PubMed ID: 15136669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Respiratory features of centronuclear myopathy in the Netherlands.
    Bouma S; Cobben N; Bouman K; Gaytant M; van de Biggelaar R; van Doorn J; Reumers SFI; Voet NB; Doorduin J; Erasmus CE; Kamsteeg EJ; Jungbluth H; Wijkstra P; Voermans NC
    Neuromuscul Disord; 2023 Jul; 33(7):580-588. PubMed ID: 37364426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy.
    Gal A; Inczedy-Farkas G; Pal E; Remenyi V; Bereznai B; Geller L; Szelid Z; Merkely B; Molnar MJ
    Clin Neuropathol; 2015; 34(2):89-95. PubMed ID: 25492887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy.
    Ceyhan-Birsoy O; Agrawal PB; Hidalgo C; Schmitz-Abe K; DeChene ET; Swanson LC; Soemedi R; Vasli N; Iannaccone ST; Shieh PB; Shur N; Dennison JM; Lawlor MW; Laporte J; Markianos K; Fairbrother WG; Granzier H; Beggs AH
    Neurology; 2013 Oct; 81(14):1205-14. PubMed ID: 23975875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.
    Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P
    Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
    Gineste C; Simon A; Braun M; Reiss D; Laporte J
    Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
    Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
    Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.